Epidemiology

You have full text access to this OnlineOpen article

Lymphoproliferative disorders in autoimmune diseases in Japan: Analysis of clinicopathological features and Epstein-Barr virus infection

  1. Yoshihiko Hoshida1,
  2. Yasuhiko Tomita1,
  3. Dong Zhiming1,
  4. Amane Yamauchi2,
  5. Shin-ichi Nakatsuka1,
  6. Yoshiko Kurasono3,
  7. Yasuhiro Arima4,
  8. Mitsuru Tsudo4,
  9. Masayuki Shintaku5,
  10. Katsuyuki Aozasa1,†,*

Article first published online: 28 OCT 2003

DOI: 10.1002/ijc.11582

Issue

International Journal of Cancer

International Journal of Cancer

Volume 108, Issue 3, pages 443–449, 20 January 2004

Additional Information

How to Cite

Hoshida, Y., Tomita, Y., Zhiming, D., Yamauchi, A., Nakatsuka, S.-i., Kurasono, Y., Arima, Y., Tsudo, M., Shintaku, M. and Aozasa, K. (2004), Lymphoproliferative disorders in autoimmune diseases in Japan: Analysis of clinicopathological features and Epstein-Barr virus infection. Int. J. Cancer, 108: 443–449. doi: 10.1002/ijc.11582

Author Information

  1. 1

    Department of Pathology, Osaka University Medical School, Osaka, Japan

  2. 2

    Department of Pathology, Kagawa University Medical School, Kagawa, Japan

  3. 3

    Department of Pathology, Yokohama City University, School of Medicine, Yokohama, Japan

  4. 4

    Department of Internal Medicine, Osaka Red Cross Hospital, Osaka, Japan

  5. 5

    Department of Pathology, Osaka Red Cross Hospital, Osaka, Japan

  1. †

    Fax: +81-6-6879-3713

*Department of Pathology (C3), Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan

Publication History

  1. Issue published online: 21 NOV 2003
  2. Article first published online: 28 OCT 2003
  3. Manuscript Accepted: 2 SEP 2003
  4. Manuscript Revised: 25 AUG 2003
  5. Manuscript Received: 13 JAN 2003

Funded by

  • Ministry of Education, Science and Culture, Japan. Grant Numbers: 12576004, 12670159, 12770087, 1270159, 14031213, 14570141

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (203K)

REFERENCES

  • 1
    JaffeES, HarrisNL, SteinH, VardimanJW. eds. Pathology and genetics, tumours of hematopoietic and lymphoid tissues. World Health Organization classification of tumours. Lyon: IARC Press, 2001.
  • 2
    Thomas E, Brewster DH, Black RJ, MacFarlane GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 2000; 88: 497–502.
    Direct Link:
  • 3
    Mellemkljer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH. Rheumatoid arthritis and cancer risk. Eur J Cancer 1996; 32A: 1753–7.
  • 4
    Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R, Fraumeni JF Jr. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993; 85: 307–11.
  • 5
    Symmons DP. Neoplasms of the immune system in rheumatic arthritis. Am J Med 1985; 78: 22–8.
  • 6
    Isomaki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chron Dis 1978; 31: 691–6.
  • 7
    Kamel OW, van de Rijin M, Weiss LM, Del Zoppo GJ, Hench PK, Robbins BA, Montgomery PG, Warnke RA, Dorfman RF. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993; 328: 1317–21.
  • 8
    Kamel OW, Holly EA, van de Rijn M, Lele C, Sah A. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. J Rheumatol 1999; 26: 1676–80.
  • 9
    Hsu S-M, Raine L, Fanger H. The use of anti-avidin antibody and avidin-biotin-peroxidase complex in immuno-peroxidase technics. Am J Clin Pathol 1981; 75: 816–21.
  • 10
    Weiss LM, Chen Y-Y, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 1991; 139: 1259–65.
  • 11
    Tomita Y, Ohsawa M, Mishiro Y, Kubo T, Maeshiro N, Kojya S, Noda Y, Aozasa K. The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan. Lab Invest 1995; 73: 190–6.
  • 12
    Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865–9.
  • 13
    Kwok S, Ehrlich G, Poiesz B, Kalish R, Sninsky JJ. Enzymatic amplification of HTLV-1 viral sequences from peripheral blood mononuclear cells and infected tissues. Blood 1988; 72: 1117–23.
  • 14
    Kwok S, Kellogg D, Ehrlich G, Poiesz B, Bhagavati S, Sninsky JJ. Characterization of a sequence of human T cell leukemia virus type I from a patient with chronic progressive myelopathy. J Infect Dis 1988; 158: 1193–7.
  • 15
    Yamauchi A, Tomita Y, Miwa H, Sakamoto H, Sugiyama H, Aozasa K. Clonal evolution of gastric lymphoma of mucosa-associated lymphoid tissue type. Mod Pathol 2001; 14: 957–62.
  • 16
    Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
  • 17
    Peto RE, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1–39.
  • 18
    Cox DR. Regression models and life-tables. J R Stat Soc (B) 1972; 34: 187–220.
  • 19
    Sheffè H. The analysis of variance. New York: Wiley, 1959.
  • 20
    Cheson BD, Horning SJ, Coiffier B, Shipp MA, Frisher RI, Connors JM, Lister TL, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillars F, Klippensten D, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma. J Clin Oncol 1999; 17: 1244–53.
  • 21
    Hoshida Y, Li T, Dong Z, Tomita Y, Yamauchi A, Hanai J, Aozasa K. Lymphoproliferative disorders in renal transplants in Japan. Int J Cancer 2001; 91: 869–75.
    Direct Link:
  • 22
    Levine AM, Seneviratne L, Espina BM, Wohl AR, Tulpule A, Nathwani BN, Gill PS. Evolving characteristics of AIDS-related lymphoma. Blood 2000; 96: 4086–90.
  • 23
    Aozasa K, Tsujimoto M, Sakurai M, Honda M, Yamashita K, Hanada M, Sugimoto A. Non-Hodgkin's lymphomas in Osaka, Japan. Eur J Cancer Clin Oncol 1985; 21: 487–92.
  • 24
    Marx J. Cancer research, anti-inflammatories inhibit cancer growth—but how? Science 2001; 291: 581–2.
  • 25
    Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995; 333: 609–14.
  • 26
    Thomas E, Brewster DH, Black RJ, MacFarlane GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 2000; 88: 497–502.
    Direct Link:
  • 27
    Miyazato H, Nakatsuka S, Miyanaga I, Hanamoto H, Tatsumi Y, Matsuda M, Maeda Y, Kanamaru A, Aozasa K and Osaka Lymphoma Study Group. Follicular lymphoma in Osaka, Japan: histological features and chronological change. Int J Hematol 2002; 76: 333–7.
  • 28
    Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173–92.
  • 29
    Hummel M, Anagnostopoulos I, Korbjuhn P, Stein H. Epstein-Barr virus in B cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high grade types. J Pathol 1995; 175: 263–71.
    Direct Link:
  • 30
    Kamel OW, van de Rijn M, LeBrun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 1994; 25: 638–43.
  • 31
    Aozasa K, Kanno H, Miwa H, Tomita Y. EBV and non-Hodgkin's lymphoma with special analysis on pyothorax-associated lymphoma. In: TakataK, ed. Current topics in microbiology and immunology. New York: Springer, 2001. p 103–20.
  • 32
    d'Amore F, Johansen P, Houmand A, Weisenburger DD, Mortensen LS. Epstein-Barr virus genome in Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T cell lymphoma and correlation with a poor prognosis. Danish lymphoma Study Group, LYFO. Blood 1996; 87: 1045–55.
  • 33
    Delecluse H-J, Kremmer E, Rouault J-P, Cour C, Bornkamm G, Berger F. The expression of Epstein-Barr virus latent protein is related to the pathological features of post-transplant lymphoproliferative disorders. Am J Pathol 1995; 146: 1113–20.
  • 34
    Kamel OW, Weiss LM, van de Rijn M, Colby TV, Kingma DW, Jaffe ES. Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy. Am J Surg Pathol 1996; 20: 1279–87.
View Full Article (HTML) Get PDF (203K)